Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Aaron Kantoff currently holds 88,281 shares of Tourmaline Bio, Inc. (TRML), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aaron Kantoff has been a net buyer of TRML stock. They have purchased $208.8K and sold $0 worth of shares.
Aaron Kantoff's most recent insider trade was on Oct 28, 2025, when they sold 88,281 shares at $0.00 per share.
Aaron Kantoff serves as Executive at Tourmaline Bio, Inc. (TRML). They have executed 10 insider transactions totaling $208.8K over their tenure at the company.
Aaron Kantoff holds the position of Executive at Tourmaline Bio, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Aaron Kantoff has shown a buying trading pattern, with $208.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Aaron Kantoff was on Nov 18, 2021, when they purchased $119.9K worth of CNTA shares. This transaction involved 10,000 shares at $11.99 per share.
Aaron Kantoff currently owns 88,281 shares of Tourmaline Bio, Inc. (TRML), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Aaron Kantoff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Aaron Kantoff has 10 Form 4 filings on record as an insider at Tourmaline Bio, Inc..
Set alerts for Aaron Kantoff and 40,000+ other insiders.